http://dspace.bsu.edu.ru/handle/123456789/52737| Title: | Future directions in cancer immunotherapy with monoclonal antibodies |
| Authors: | Lucía Cabello-Alemán |
| Keywords: | medicine pharmacology antibodies cancer disease emerging alternatives treatment |
| Issue Date: | 2022 |
| Citation: | Lucía Cabello-Alemán. Future directions in cancer immunotherapy with monoclonal antibodies / Lucía Cabello-Alemán ; Faculty of Sciences, University of Granada // Research Results in Pharmacology. - 2022. - Vol.8, №4.-P. 101-107. - Doi: 10.3897/rrpharmacology.8.85918. - Refer.: p. 105-107. |
| Abstract: | Cancer immunotherapy with monoclonal antibodies (mAbs) has become a therapy with great potential nowadays. It is based on the affinity of antibodies to bind to specific molecules, thus inhibiting the growth and spread of cancer. This mini-review will discuss the emerging alternatives of cancer immunotherapies based on mAbs |
| URI: | http://dspace.bsu.edu.ru/handle/123456789/52737 |
| Appears in Collections: | Vol. 8, № 4 |
| File | Description | Size | Format | |
|---|---|---|---|---|
| Aleman_Future_22.pdf | 670.2 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.